Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.30 |
| ▸ | RAB9A | P51151 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13485617 | 0.86 | ALDH1A1 (0.48) | NPSR1ALDH1A1L3MBTL1LMNAGAA | |
| SCHEMBL13485618 | 0.86 | ALDH1A1 (0.42) | NPSR1ALDH1A1GAAKMT2AMEN1 | |
| SCHEMBL25844789 | 0.80 | NPSR1 (0.35) | NPSR1ALDH1A1 | |
| SCHEMBL25844986 | 0.78 | NPSR1 (0.35) | NPSR1ALDH1A1L3MBTL1LMNAKMT2A | |
| SCHEMBL12204997 | 0.75 | ALDH1A1 (0.46) | NPSR1ALDH1A1L3MBTL1LMNAGAA | |
| SCHEMBL22131512 | 0.74 | — | — | |
| SCHEMBL26437481 | 0.74 | ALDH1A1 (0.41) | NPSR1ALDH1A1GAAKMT2AMEN1 | |
| SCHEMBL21421503 | 0.73 | ALDH1A1 (0.40) | NPSR1ALDH1A1LMNAGAAKMT2A | |
| SCHEMBL12159398 | 0.73 | ALDH1A1 (0.40) | NPSR1ALDH1A1GAAKMT2AMEN1 | |
| SCHEMBL17264819 | 0.71 | NPSR1 (0.43) | NPSR1ALDH1A1L3MBTL1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230131429-A1 | PHOTO-DECOMPOSABLE COMPOUND, PHOTORESIST COMPOSITION INCLUDING THE SAME, AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230131429-A1 | PHOTO-DECOMPOSABLE COMPOUND, PHOTORESIST COMPOSITION INCLUDING THE SAME, AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230131429-A1 | PHOTO-DECOMPOSABLE COMPOUND, PHOTORESIST COMPOSITION INCLUDING THE SAME, AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE | C9, ERCC1, SMARCC2 | NPSR1 4385/4885ALDH1A1 3796/4885L3MBTL1 849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.